×
NeuroOne Medical Technologies Long Term Debt 2021-2025 | NMTC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
NeuroOne Medical Technologies long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.
View More
NeuroOne Medical Technologies Long Term Debt 2021-2025 | NMTC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
NeuroOne Medical Technologies long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$145.2B
CVS Health (CVS)
$74.3B
Elevance Health (ELV)
$63.1B
Cencora (COR)
$56.3B
DiDi Global (DIDIY)
$26.2B
Labcorp Holdings (LH)
$22.4B
Natera (NTRA)
$19.3B
BioMerieux (BMXMF)
$16B
ICON (ICLR)
$15.7B
EUROFINS SCIENT (ERFSF)
$14.8B
CochLear (CHEOY)
$13.4B
Medpace Holdings (MEDP)
$12.8B
Solventum (SOLV)
$12.8B
Revvity (RVTY)
$12B
Viatris (VTRS)
$11B
Avantor (AVTR)
$9.5B
Sonic Healthcare (SKHHY)
$9.3B
Charles River Laboratories (CRL)
$8.7B
HealthEquity (HQY)
$8.2B
Caris Life Sciences,�Inc (CAI)
$7.5B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.4B
Surgery Partners (SGRY)
$2.7B
Organon (OGN)
$2.6B
Concentras Parent (CON)
$2.5B
GeneDx Holdings (WGS)
$2.3B
Alignment Healthcare (ALHC)
$2.3B
Progyny (PGNY)
$2B